Different model though. Everything about Medavisor entails fostering a closer relationship between medical professional (GP, Pharmacist etc) and patient and that's how I think they'll make the bulk of their revenue as things progress. From what I can tell (unless there's been changes) Doctus is more about providing very basic access to "low risk" medications for more Australians and especially remote populations? Not saying it won't capture any of Medadvisor's potential market but unless I'm mistaken, they seem to be on different paths, except for the one aspect. There's also the $24.95 consultation fee with Doctus and I imagine (can't find the details) an express delivery fee. Would think plenty of room for both?
Add to My Watchlist
What is My Watchlist?
